Human bFGF/FGF2(Basic Fibroblast Growth Factor) ELISA Kit
中文名称：人碱性成纤维细胞生长因子(bFGF/FGF2)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 31.25-2000 pg/mL
- 灵敏度： 18.75 pg/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人bFGF/FGF2抗体包被于酶标板上，实验时样品（或标准品）中的人bFGF/FGF2会与包被抗体结合。后依次加入生物素化的抗人bFGF/FGF2抗体和辣根过氧化物酶标记的亲和素，抗人bFGF/FGF2抗体与结合在包被抗体上的人bFGF/FGF2结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，bFGF/FGF2浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中bFGF/FGF2的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 31.25-2000 pg/mL |
| 灵敏度 | 18.75 pg/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人bFGF/FGF2，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
Neurons enhance blood–brain barrier function via upregulating claudin-5 and VE-cadherin expression due to glial cell line-derived neurotrophic factor secretion
IF: 6.400 -
Biological properties and characterization of several variations of a clinical human plasma-based skin substitute (HPSS) model and its manufacturing process
IF: 5.600Journal： Regenerative Biomaterials (2024)Reactivity：HumanSample Type：human plasma-based skin substitute (HPSSs) -
Preclinical evaluation on human platelet lysate for the treatment of secondary injury following intracerebral hemorrhage
IF: 3.500Journal： BRAIN RESEARCH BULLETIN (2024)Reactivity：HumanSample Type：Human platelet lysate (HPL) -
Long-term stability of frozen platelet-rich plasma under??80?°C storage condition
IF: 3.400Journal： Regenerative Therapy (2024)Reactivity：HumanSample Type：Platelet rich plasma (PRP) -
Evaluation of the genotoxicity, cytotoxicity, and bioactivity of calcium silicate-based cements
IF: 2.900 -
Lipopolysaccharide-Educated Cancer-Associated Fibroblasts Facilitate Malignant Progression of Ovarian Cancer Cells via the NF-kB/IL-6/JAK2 Signal Transduction
IF: 2.600 -
Apigenin inhibits epithelial mesenchymal transition in renal tubular epithelial cells through PI3K/AKT and NF-κB pathways for treating renal fibrosis
IF: 2.600 -
Predictors of fibrogenesis in children with JIA: a single-center pilot study
IF: 2.500 -
The impact of hsa-miR-1972 on the expression of von Willebrand factor in breast cancer progression regulation
IF: 2.300 -
POS0765?SERUM BASIC FIBROBLAST GROWTH FACTOR IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS
IF: 27.400Journal： ANNALS OF THE RHEUMATIC DISEASES (2023)Reactivity：HumanSample Type：serum
实验操作视频
